DKMS vs Veeva

Postcode Lotterie fördert DKMS mit 1,5 Millionen Euro

Die DKMS News & Stories Seite zeigt neue Einträge, darunter die Förderung durch die Postcode Lotterie mit 1,5 Millionen Euro, den World Marrow Donor Day 2026, eine Spende von INTERSPORT Deutschland über 50.000 Euro sowie die Erweiterung der globalen Geschäftsführung um Katharina Harf und Prof. Dr. Johannes Schetelig.

INTERSPORT Deutschland spendet 50.000 Euro an die DKMS

INTERSPORT Deutschland unterstützt unsere Arbeit im Kampf gegen Blutkrebs mit einer Spende in Höhe von 50.000 Euro.

Katharina Harf und Prof. Dr. Johannes Schetelig verstärken globale Geschäftsführung der DKMS

Konsequente Erweiterung strategischer Rollen für die DKMS als wachsende internationale Organisation

IQVIA Expands Veeva Partnership with Clinical Operations Applications

IQVIA and Veeva Systems announced an expansion of their partnership, with IQVIA selecting Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications for its clinical development studies. This extends the previously announced EDC partnership. The collaboration aims to increase trial speed and efficiency, strengthen site centricity, and improve decision-making for clinical research customers. All Veeva clinical solutions will also be available through IQVIA for sponsors seeking a full Veeva technology stack. Executives from both companies emphasized the benefits of integrated technologies and customer flexibility in choosing EDC, RTSM, and eCOA solutions. The announcement was made on October 13, 2026, ahead of the Veeva R&D and Quality Summit scheduled for October 20-21 in Boston.

• IQVIA selected Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications.
• Partnership expansion extends the previously announced EDC partnership.
• All Veeva clinical solutions will be available through IQVIA for sponsors.

Servier Adopts Veeva OpenData Globally for AI

Servier, a French pharmaceutical company, is standardizing its customer reference data across more than 80 countries with Veeva OpenData, part of Veeva Data Cloud. This initiative builds on Servier's use of Veeva Link Key People and aims to create an AI-ready data foundation by harmonizing fragmented data silos. The centralized data will help commercial and medical teams gain faster insights and improve efficiency. Liam Hanrahan, Director of Global Operations Excellence at Servier, highlighted that the centralized data will improve processes and enable a semantic layer for better engagement with key healthcare professionals. Veeva's president, Kilian Weiss, emphasized that 89% of AI initiatives fail due to data challenges, and Servier's data-first approach demonstrates industry leadership. The adoption replaces fragmented silos and ensures consistency for scaling advanced analytics and AI.

• Servier standardizes customer reference data with Veeva OpenData across more than 80 countries.
• The initiative builds on Servier's use of Veeva Link Key People.
• Veeva OpenData is part of Veeva Data Cloud, which also includes Veeva Link and Veeva Compass.

New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day

Veeva announces a new Study Builder Agent that can configure clinical studies in as little as one day, along with other updates including another Top 20 biopharma choosing Vault CRM and the introduction of Falcon Router for agentic triage.